News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Moderna Announces Plan to Expand Commercial Footprint in Europe Across Six Additional Countries

    adminFebruary 22, 202201.9k views

    Synopsis : Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across…

    Read more

    ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion

    adminFebruary 22, 202201.9k views

    Synopsis : ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global,…

    Read more

    Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics

    adminFebruary 22, 202201.8k views

    Summary : Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities…

    Read more

    Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US

    adminFebruary 22, 202202k views

    Synopsis : Recipharm, a leading global contract development and manufacturing organisation (CDMO), announced the acquisition of Arranta Bio, a prominent advanced therapy…

    Read more

    BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer

    adminFebruary 22, 202201.6k views

    Summary – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing on the…

    Read more

    Bayer delivers on medical innovation fueling transformation of pharma business

    adminFebruary 22, 202201.8k views

    Summary : At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business,…

    Read more

    Alexion and UK patient advocacy groups launch video campaign

    adminFebruary 21, 202201.9k views

    Summary : Rare Disease Day has inspired a pioneering video to support patients living with rare conditions Alexion Pharma UK has launched…

    Read more

    Syncona announces sale of portfolio company to Novartis

    adminFebruary 21, 202201.7k views

    Synopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale…

    Read more

    Covaxin gets nod for human clinical trials in the US

    adminFebruary 21, 202201.5k views

    Summary : After a long wait, Bharat Biotech’s Covaxin has finally got the nod from the US Food and Drug Administration (USFDA)…

    Read more

    Covid reinfections: Are they milder and do they strengthen immunity?

    adminFebruary 21, 202201.7k views

    We’ve known since early on in the pandemic that Covid reinfections could occur. One of the first reinfections reported was in a…

    Read more

    Posts navigation

    1 … 39 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top